ABLYNX Inactive Instrument
Company Ablynx CBOE EUROPE EQUITIES
Equities
0HNK
BE0003877942
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 2018 | AstraZeneca : Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit | RE |
| 2018 | Sanofi : sees new acquisitions and drugs reviving growth | RE |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Petrus Houwen
CEO | Chief Executive Officer | - | 31/03/19 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/03/19 | |
Pieter Oldenziel
BRD | Director/Board Member | - | 31/12/18 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 78,001,392 | 77,221,378 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +38.66% | 52.85B | |
| -7.81% | 38.87B | |
| +35.40% | 38.24B | |
| -10.77% | 26.79B | |
| +11.77% | 26.16B | |
| -17.82% | 19.9B | |
| +35.09% | 13.18B | |
| +29.17% | 12.24B | |
| -3.05% | 11.79B |
- Stock Market
- Equities
- ABLX Stock
- 0HNK Stock
- Company Ablynx
